Skip to main content
. 2026 Oct 29;17:1947706. doi: 10.3389/fpsyt.2026.1947706

Table 4.

Concomitant psychotropic treatment, co-prescribed agents and CGI-I outcome by treatment type.

Variable All patients, n (%) N = 650 Concomitant treatment, n (%) n = 285
Concomitant treatment (clinician-coded)
No (antidepressant monotherapy) 365 (56.2) –
Yes 285 (43.8) –
Reason for concomitant treatment, n = 285
Comorbid psychiatric condition – 158 (55.4)
Partial response (augmentation) – 125 (43.9)
Not specified – 2 (0.7)
Co-prescribed psychotropic agents recorded
Any co-prescribed psychotropic agent 349 (53.7) 266 (93.3)
Antipsychotics 236 (36.3) 229 (80.4)
 Risperidone 114 (17.5) 109 (38.2)
 Aripiprazole 61 (9.4) 59 (20.7)
 Quetiapine 29 (4.5) 29 (10.2)
 Haloperidol 19 (2.9) 19 (6.7)
 Olanzapine 15 (2.3) 15 (5.3)
 Zuclopenthixol 1 (0.2) 1 (0.4)
 Chlorpromazine 1 (0.2) 1 (0.4)
ADHD medications 147 (22.6) 67 (23.5)
 OROS methylphenidate 64 (9.8) 33 (11.6)
 Immediate-release methylphenidate 34 (5.2) 6 (2.1)
 Atomoxetine 49 (7.5) 28 (9.8)
Mood stabilisers 17 (2.6) 17 (6.0)
 Sodium valproate 11 (1.7) 11 (3.9)
 Lithium 4 (0.6) 4 (1.4)
 Carbamazepine 2 (0.3) 2 (0.7)
Benzodiazepines 15 (2.3) 15 (5.3)
 Alprazolam 8 (1.2) 8 (2.8)
 Clonazepam 5 (0.8) 5 (1.8)
 Lorazepam 1 (0.2) 1 (0.4)
 Diazepam 1 (0.2) 1 (0.4)
Other agents 24 (3.7) 24 (8.4)
 Propranolol 24 (3.7) 24 (8.4)
 Hydroxyzine 1 (0.2) 1 (0.4)
CGI-I at last recorded follow-up
Positive response (1–2), monotherapy, n = 365 363 (99.5) –
Positive response (1–2), concomitant treatment, n = 285 – 187 (65.6)

Concomitant treatment was coded by the treating clinician as the addition of another psychotropic agent because of a comorbid psychiatric condition or partial response. Co-prescribed agents are those recorded in the medical record at the time of antidepressant treatment; some patients coded as receiving monotherapy had an ADHD medication (or, rarely, an antipsychotic) recorded, and some patients received more than one co-prescribed agent. CGI-I, Clinical Global Impression–Improvement; OROS, osmotic-release oral system.